Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology: Workshop Summary (2013)
Chapter: Appendix D: Registered Attendees
Appendix D
Registered Attendees
Scott Allocco
BioMarker Strategies
Eric Assaraf
WRG
Erin Balogh
Institute of Medicine
Robert Bast
University of Texas MD Anderson Cancer Center
Jessica Bayh
Applied Policy
Al Benson III
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Marian Birkeland
National Comprehensive Cancer Network
Mary Bordoni
Personalized Medicine Coalition
Jennifer Bowman
American Clinical Laboratory Association
Pamela Bradley
American Association for Cancer Research
Joel Brill
Predictive Health, LLC
Jeffrey Bush
BD
Khatereh Calleja
AdvaMed
Allen Egon Cholakian
IRDF Project Harvard/Columbia
Deborah Collyar
Patient Advocates in Research
Jeff Cossman
USDS, Inc.
Robin Harper Cowie
Biodesix, Inc.
Claude Desjardins
Johns Hopkins Bloomberg School of Public Health
Patricia Deverka
Center for Medical Technology Policy
Vamil Divan
Credit Suisse
Noel Doheny
Epigenomics, Inc.
Sarah Donovan
Avalere
Georgia Dunston
Howard University
Tania Dutta
Center for Medical Technology Policy
Christopher Earl
Innotrove, LLC
Raith Erickson
Complete Genomics
Lloyd Everson
The U.S. Oncology Network
Kelly Filipski
National Cancer Institute
Andrew Freedman
National Cancer Institute
Gwen Gordon
Personalized Medicine Coalition
Daniel Grosu
Illumina, Inc.
Valerie Hutchins
HillCo HEALTH
Usman Iqbal
Sanofi
Ram Iyer
Inova Health Systems
Leila Jamal
Kennedy Krieger Institute
Elaine Jeter
Palmetto GBA
Brett Johnson
International Cancer Advocacy Network
Roger Klein
University of South Florida School of Medicine
Hon-Sum Ko
U.S. Food and Drug Administration
Nicole Kuderer
Duke University
Hanns Kuttner
Hudson Institute
Gabriela Lavezzari
Express Scripts
Debra Leonard
Weill Cornell Medical Center
Rachel Lindor
Arizona State University College of Law
Tracy Lively
National Cancer Institute
Gary Lyman
Duke University School of Medicine; Duke Cancer Institute
Julie Lynch
U.S. Department of Veterans Affairs
Elizabeth Mansfield
U.S. Food and Drug Administration
Stephen Marmaras
Biotechnology Industry Organization
Robert McCormack
Veridex, LLC
Robert McDonough
Aetna
Mary McGrane
U.S. Department of Agriculture
Lisa McShane
National Cancer Institute
Kala Menon
Booz Allen Hamilton
Donna Messner
Center for Medical Technology Policy
Douglas Moeller
McKesson Health Solutions
Padmaja Mummaneni
U.S. Food and Drug Administration
Bill Murray
Cepheid
David Nelson
EPIC Sciences
Lee Newcomer
United HealthCare Corporation
R. Hannes Niedner
5AM Solutions, Inc.
Danielle Pambianco
HillCo HEALTH
David Parkinson
Nodality
Scott Patterson
Amgen, Inc.
Edmund Pezalla
Aetna
Kathryn Phillips
University of California, San Francisco, Center for Translational and Policy Research on Personalized Medicine
Steve Phurrough
Center for Medical Technology Policy
Margaret Piper
Technology Evaluation Center, Blue Cross Blue Shield Association
Bruce Quinn
Foley Hoag, LLP
Samantha Roberts
Friends of Cancer Research
Jeffrey Roche
Centers for Medicare & Medicaid Services
Greg Rossi
AstraZeneca UK
Drew Saelens
Applied Policy
Howard Scher
Memorial Sloan-Kettering Cancer Center
Richard Schilsky
Comprehensive Cancer Center, University of Chicago
Michele Schoonmaker
Cepheid
Beverlyn Settles-Reaves
Howard University
Paul Sheives
Biotechnology Industry Organization
Naoko Simonds
National Cancer Institute
Mary Lou Smith
Research Advocacy Network
Stuart Spector
Center for Medical Technology Policy
Merianne Spencer
Center for Medical Technology Policy
Sylvia Trujillo
American Medical Association
Sean Tunis
Center for Medical Technology Policy
Jessica Walrath
Friends of Cancer Research
Corinne Warren
Center for Medical Technology Policy
Richard Wenstrup
Myriad Genetic Laboratories
Elizabeth West
FasterCures
Wendy Wifler
Agendia, Inc.
Marc Williams
Geisinger Health System
Dara Wright
Affymetrix
Amy Zettle
Potomac Research Group
This page intentionally left blank.
